Xeris Biopharma Holdings Inc (XERS)
EBITDA
$16.59M
TTM · Period ending: · USD
XERS EBITDA
Latest reported$16.59Mperiod ending
Latest reported$16.59Mperiod ending
XERS EBITDA (-$13.09M → $16.59M)
Annual EBITDA
High-resolution chart · PNG
XERS ebitda history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA (USD) |
|---|---|
| 12,710,000 | |
| -13,994,000 | |
| -23,735,000 | |
| -69,314,000 | |
| -113,666,000 | |
| -79,123,000 | |
| -117,797,000 | |
| -57,215,000 | |
| -26,377,000 | |
| -13,091,000 |